Mitochondrial dysfunction–induced H3K27 hyperacetylation perturbs enhancers in Parkinson’s disease-Reference-Cited by-同舟云学术

Mitochondrial dysfunction–induced H3K27 hyperacetylation perturbs enhancers in Parkinson’s disease

Published:2021-09-08 Issue:17 Volume:6 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Huang Minhong,Lou Dan,Charli Adhithiya,Kong Dehui,Jin Huajun,Zenitsky Gary^ORCID,Anantharam Vellareddy,Kanthasamy Arthi,Wang Zhibin,Kanthasamy Anumantha G.^ORCID

Funder

NIH Office of the Director

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/138088/files/pdf

Reference94 articles.

1. Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

2. Environmental Toxins and Parkinson's Disease

3. Genetic Animal Models of Parkinson's Disease

4. Mitochondrial Dysfunction in Genetic Animal Models of Parkinson's Disease

5. Environmental and genetic variables influencing mitochondrial health and Parkinson’s disease penetrance;Zanon;Parkinsons Dis,2018

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondrial stress-induced H4K12 hyperacetylation dysregulates transcription in Parkinson’s disease;Frontiers in Cellular Neuroscience;2024-08-12

2. Age-related energetic reprogramming in glial cells: possible correlations with Parkinson’s disease;Ageing and Neurodegenerative Diseases;2024-07-17

3. A crazy trio in Parkinson's disease: metabolism alteration, α-synuclein aggregation, and oxidative stress;Molecular and Cellular Biochemistry;2024-04-16

4. Inhibition of EHMT1/2 rescues synaptic damage and motor impairment in a PD mouse model;Cellular and Molecular Life Sciences;2024-03-12

5. Small-molecule LRRK2 inhibitors for PD therapy: Current achievements and future perspectives;European Journal of Medicinal Chemistry;2023-08